[HTML][HTML] Update on transfusion-related acute lung injury: an overview of its pathogenesis and management

Y Yu, Z Lian - Frontiers in Immunology, 2023 - frontiersin.org
Transfusion-related acute lung injury (TRALI) is a severe adverse event and a leading cause
of transfusion-associated death. Its poor associated prognosis is due, in large part, to the …

Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome

Y Xu, L Lv, Q Wang, Q Yao, L Kou, H Zhang - Colloids and Surfaces B …, 2024 - Elsevier
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are serious lung
injuries caused by various factors, leading to increased permeability of the alveolar-capillary …

Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage

C Beck, D Ramanujam, P Vaccarello… - Nature …, 2023 - nature.com
Recent studies of severe acute inflammatory lung disease including COVID-19 identify
macrophages to drive pulmonary hyperinflammation and long-term damage such as fibrosis …

[HTML][HTML] Forsythiaside A alleviates acute lung injury by inhibiting inflammation and epithelial barrier damages in lung and colon through PPAR-γ/RXR-α complex

J Wang, X Xue, X Zhao, L Luo, J Liu, S Dai… - Journal of Advanced …, 2024 - Elsevier
Introduction Acute lung injury (ALI) is a lung disease characterized by inflammation and still
requires further drug development. Forsythiaside A as the active compound of Forsythiae …

Neutrophil extracellular traps contribute to immunothrombosis formation via the STING pathway in sepsis-associated lung injury

S Zhu, Y Yu, M Qu, Z Qiu, H Zhang, C Miao… - Cell Death Discovery, 2023 - nature.com
Neutrophil extracellular traps (NETs) are involved in the activation and dysfunction of
multiple overlapping and interacting pathways, including the immune response to injury …

An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society Clinical Practice Guideline

N Qadir, S Sahetya, L Munshi, C Summers… - American journal of …, 2024 - atsjournals.org
Background: This document updates previously published Clinical Practice Guidelines for
the management of patients with acute respiratory distress syndrome (ARDS), incorporating …

Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients

E Duijvelaar, J Gisby, JE Peters, HJ Bogaard… - Nature …, 2024 - nature.com
The pathobiology of respiratory failure in COVID-19 consists of a complex interplay between
viral cytopathic effects and a dysregulated host immune response. In critically ill patients …

Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial

LN Atmowihardjo, JR Schippers, E Duijvelaar… - Critical Care, 2023 - Springer
Purpose A hallmark of acute respiratory distress syndrome (ARDS) is hypoxaemic
respiratory failure due to pulmonary vascular hyperpermeability. The tyrosine kinase …

Acute respiratory distress syndrome; a review of recent updates and a glance into the future

HF Ramji, M Hafiz, HH Altaq, ST Hussain, F Chaudry - Diagnostics, 2023 - mdpi.com
Acute respiratory distress syndrome (ARDS) is a rapidly progressive form of respiratory
failure that accounts for 10% of admissions to the ICU and is associated with approximately …

Alpha-linolenic acid pretreatment alleviates NETs-induced alveolar macrophage pyroptosis by inhibiting pyrin inflammasome activation in a mouse model of sepsis …

C Liu, Y Zhou, Q Tu, L Yao, J Li, Z Yang - Frontiers in Immunology, 2023 - frontiersin.org
Background Neutrophil extracellular traps (NETs) can cause acute lung injury (ALI)/acute
respiratory distress syndrome (ARDS) by inducing macrophage pyroptosis. The purpose of …